Behavioral Psychedelics: Integrating Mind and Behavior to Improve Health and Resilience
Frontiers in Psychiatry – March 14, 2022
Source: OpenAlex
Summary
Psychedelics, often from chemical synthesis and alkaloids, offer immense potential for mental health, particularly for anxiety. While Psychology and Psychiatry recognize their public health promise, clinical psychology currently lacks standardized methods for integrating these drug studies with psychotherapist-led interventions. There are no established metrics or consensus on effectiveness. Developing clear guidelines for combining psychotherapy and psychedelics to foster lasting behavioral change is essential to fully harness this therapeutic avenue.
Abstract
One of the most recent and potentially promising advancements in the health sciences has involved the attempted use of psychedelics for treating mental and behavioral health problems, such as anxiety, depression, posttraumatic stress disorder, and addiction. Despite surging scientific and public interest in this work, however, we presently have no standard of care or consensus regarding how best to combine psychotherapy and psychedelics or to assess effectiveness. We discuss these timely issues here through the lens of behavioral psychedelics , which we define as the study of psychedelics to foster intentional changes in habits and behaviors to improve health and resilience. Psychedelics may have the potential to reduce chronic disease risk caused by mental and behavioral rigidity. To fully realize this potential, though, we believe the field must establish best practices and guidelines that include how to induce lasting changes in behavior.